Salmeterol

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3017 publications

FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner.

FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner.

Journal: bioRxiv : the preprint server for biology

Published: March 23, 2026

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

Journal: JAMA network open

Published: March 09, 2026

Single vs Dual Lactose-Polyethylene Glycol 3000 Microcarrier Systems for Pulmonary Salmeterol and Fluticasone Targeted Delivery.

Single vs Dual Lactose-Polyethylene Glycol 3000 Microcarrier Systems for Pulmonary Salmeterol and Fluticasone Targeted Delivery.

Journal: Drug design, development and therapy

Published: December 03, 2025

Is dual bronchodilation a cost-effective alternative to ICS/LABA in COPD? A Colombian healthcare system evaluation.

Is dual bronchodilation a cost-effective alternative to ICS/LABA in COPD? A Colombian healthcare system evaluation.

Journal: Expert review of respiratory medicine

Published: October 28, 2025

Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control.

Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 16, 2025

Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β2-Adrenoceptor Agonists.

Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β2-Adrenoceptor Agonists.

Journal: Biochemistry

Published: August 07, 2025

Comparative effectiveness of fixed-dose inhaled corticosteroid/long-acting beta-agonist therapy in adult patients with asthma.

Comparative effectiveness of fixed-dose inhaled corticosteroid/long-acting beta-agonist therapy in adult patients with asthma.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: July 29, 2025

Brain-targeting nanocages treat Alzheimer's disease via regulating microglial polarization and remodeling microenvironment.

Brain-targeting nanocages treat Alzheimer's disease via regulating microglial polarization and remodeling microenvironment.

Journal: International journal of pharmaceutics

Published: July 19, 2025

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

Journal: JAMA internal medicine

Published: July 07, 2025

Drug-Associated Alcohol Intolerance: A Real-World Disproportionality Analysis Study.

Drug-Associated Alcohol Intolerance: A Real-World Disproportionality Analysis Study.

Journal: Hospital pharmacy

Published: June 30, 2025

Clinical efficacy of Chaipu Decoction combined with Seretide in the treatment of bronchial asthma and its impact on TNF-α and CD4+/CD8.

Clinical efficacy of Chaipu Decoction combined with Seretide in the treatment of bronchial asthma and its impact on TNF-α and CD4+/CD8.

Journal: Scientific reports

Published: June 25, 2025

Mitigating End-Stage Fatigue: Acute Inhaled Salmeterol Preserves Sprint Power in Simulated Cycling.

Mitigating End-Stage Fatigue: Acute Inhaled Salmeterol Preserves Sprint Power in Simulated Cycling.

Journal: Scandinavian journal of medicine & science in sports

Published: June 11, 2025

Showing 1-12 of 3,017

Last Updated: 04/28/2026